Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

November 17, 2017

Primary Completion Date

June 17, 2019

Study Completion Date

June 17, 2019

Conditions
Influenza A H3N2Influenza A H1N1
Interventions
BIOLOGICAL

FLU-IGIV

Single dose, sterile liquid formulation for IV administration.

OTHER

Placebo for FLU-IGIV

Single dose, normal saline solution for IV administration.

Trial Locations (55)

10467

Montefiore Medical Center, The Bronx

14004

Reina Sofia University Hospital, Córdoba

15212

Allegheny General Hospital, Pittsburgh

18015

St Luke's University Health Network, Bethlehem

19141

Einstein Medical Center, Philadelphia

19611

Reading Hospital, West Reading

19718

Christiana Care Health Systems, Newark

21287

John Hopkins Hospital, Baltimore

24014

Carilion Medical Center, Roanoke

27403

Pulmonlx LLC Pulmonary & Critical Care Medicine, Greensboro

27599

University of North Carolina, Chapel Hill

30342

Northside Hospital, Atlanta

30350

Atlanta Institute for Medical Research Inc., Atlanta

30912

Augusta University, Augusta

35294

University of Alabama at Birmingham, Birmingham

43007

Hospital Universitari de Tarragona Joan XXIII, Tarragona

45409

Premier Health Miami Valley Hospital, Dayton

48075

Providence-Providence Park Hospital, Southfield, Southfield

48201

Wayne State University/Detroit Receiving Hospital, Detroit

48202

Wayne State University/Sinai Grace Hospital, Detroit

52242

University of Iowa, Iowa City

55905

Mayo Clinic, Rochester

57701

Regional Health, Rapid City

60611

Northwestern University, Chicago

60637

University of Chicago, Chicago

63110

Washington University, St Louis

66160

University of Kansas medical Center, Kansas City

72205

Baptist Health Center for Clinical Research, Little Rock

73104

University of Oklahoma, Oklahoma City

75390

UT Southwestern Medical Center, Dallas

77030

Baylor University Medical Center, Dallas

Baylor College of Medicine, Houston

Michael E. DeBakey VA Medical Center, Houston

78229

UT Health San Antonio, San Antonio

80212

Denver public Health, Denver

84108

University of Utah HealthCare, Salt Lake City

85258

HonorHealth, Scottsdale

89102

University Medical Center of Southern Nevada, Las Vegas

92868

University of California, Irvine Emergency Medicine, Orange

98405

MultiCare Institute for Research & Innovation, Tacoma

985400

University of Nebraska Medical Center, Omaha

06519

Yale University School of Medicine, New Haven

02114

Massachusetts General Hospital, Boston

01605

University of Massachusetts Memorial Medical Center, Worcester

T2N 2T9

Foothills Medical Centre, Calgary

R3A 1R9

Health Sciences Center, Winnipeg

St. Boniface Hospital, Winnipeg

R3J 3M7

Grace Hospital, Winnipeg

G5L 5T1

CISSS BSL/Hopital Regional de Rimouski, Rimouski

G8Z 3R9

Ciusss McQ, Trois-Rivières

00680

Mayaguez Medical Center, Mayagüez

00780

San Cristobal Hospital, Ponce

08036

Hospital Clinic of Barcelona, Barcelona

Hospital del Mar, Barcelona

08225

Hospital Universitari Mutua Terrassa, Barcelona

Sponsors
All Listed Sponsors
lead

Emergent BioSolutions

INDUSTRY